Clinical Trials Update: Oct. 4, 2007
Heart Failure Bladder Disorders Fibromyalgia
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate a device for people with heart failure who need circulatory assistance while awaiting a heart transplant. To qualify, you must be at least 18, listed with UNOS as status 1, and be able to return to the clinic for routine followup. You will not qualify if you are pregnant or breastfeeding, if you've had a stroke within 90 of the study or if you've had therapy with an experimental device or drug within 30 days of the study. Additional criteria apply.
The research site is in the Bronx, N.Y.
To participate in this study for women with overactive bladder (OAB), you must be aged 18 to 75, have had OAB symptoms for at least six months, and cannot be pregnant or breastfeeding. All office visits, study related medical evaluations, and investigational medication will be provided at no cost, and compensation for time and travel is provided.
The research site is in Hackensack, N.J.
This study will evaluate an investigational medication for fibromyalgia. Participants will receive the study medication and study related physical and diagnostic evaluations at no cost. To qualify, you must be aged 18 to 65, and must have had fibromyalgia symptoms for at least three months. Additional criteria apply.
The research site is in Peoria, Ariz.
Copyright 2007 Thomson CenterWatch. All rights reserved.